[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Download PDF
Figure 1.
 Images from magnetic resonance examination of patient 1, posttransplant days 22 and 28 (GE 1.5T Signa system; General Electric, Fairfield, Conn). Axial fluid-attenuated inversion recovery image sequences of posttransplant day 22 demonstrate subtle leptomeningeal enhancement (A) and signal elevation within the pontomesencephalic junction (B); those of posttransplant day 28 reveal marked, nearly symmetric signal change within the anterior temporal lobes, hippocampi, basal ganglia, and brainstem (C, D). A coronal fast spin-echo inversion recovery image of posttransplant day 28 shows profound hyperintense signal changes throughout the undersurface of the frontal lobes and head of the caudate nuclei (E).

Images from magnetic resonance examination of patient 1, posttransplant days 22 and 28 (GE 1.5T Signa system; General Electric, Fairfield, Conn). Axial fluid-attenuated inversion recovery image sequences of posttransplant day 22 demonstrate subtle leptomeningeal enhancement (A) and signal elevation within the pontomesencephalic junction (B); those of posttransplant day 28 reveal marked, nearly symmetric signal change within the anterior temporal lobes, hippocampi, basal ganglia, and brainstem (C, D). A coronal fast spin-echo inversion recovery image of posttransplant day 28 shows profound hyperintense signal changes throughout the undersurface of the frontal lobes and head of the caudate nuclei (E).

Figure 2.
 For patient 4, axial fluid-attenuated inversion recovery image sequences of posttransplant day 34 demonstrate considerable signal elevation within the caudate, putamina, thalami, and dorsal midbrain without associated hemorrhage (A, B). An axial diffusion weighted image shows ischemic changes within the bilateral perirolandic area (C).

For patient 4, axial fluid-attenuated inversion recovery image sequences of posttransplant day 34 demonstrate considerable signal elevation within the caudate, putamina, thalami, and dorsal midbrain without associated hemorrhage (A, B). An axial diffusion weighted image shows ischemic changes within the bilateral perirolandic area (C).

Figure 3. Hematoxylin-eosin–stained sections demonstrate multiple glial nodules within the midbrain (A) and an eosinophilic intracytoplasmic inclusion body (Negri body) within one of the preserved neurons of the inferior olivary nucleus from patient 1 (B). A brisk lymphohistiocytic inflammatory infiltrate and perivascular inflammation involving the inferior olivary nucleus (C) and a preserved Purkinje cell containing a Negri body from patient 2 (D). Original magnification was ×10 for A and C; ×40 for B and D.

Figure 3. Hematoxylin-eosin–stained sections demonstrate multiple glial nodules within the midbrain (A) and an eosinophilic intracytoplasmic inclusion body (Negri body) within one of the preserved neurons of the inferior olivary nucleus from patient 1 (B). A brisk lymphohistiocytic inflammatory infiltrate and perivascular inflammation involving the inferior olivary nucleus (C) and a preserved Purkinje cell containing a Negri body from patient 2 (D). Original magnification was ×10 for A and C; ×40 for B and D.

Table 1. 
 Characteristics of Donor and Transplant Recipients
Characteristics of Donor and Transplant Recipients
Table 2. 
 Known Symptoms Associated With Rabies Exhibited in Donor and Transplant Recipients*
Known Symptoms Associated With Rabies Exhibited in Donor and Transplant Recipients*
Table 3. 
 Summary of Electroencephalogram Findings
Summary of Electroencephalogram Findings
1.
Noah  DLDrenzek  CLSmith  JS  et al.  Epidemiology of human rabies in the United States, 1980 to 1996. Ann Intern Med 1998;128922- 930
PubMedArticle
2.
Centers for Disease Control and Prevention Cases of rabies in human beings in the United States, by circumstances of exposure and rabies virus variant, 1990-2001.  Available at:http://www.cdc.gov/ncidod/dvrd/rabies/professional/publications/surveillance/surveillance01/table2-01.htm. Accessed September 7, 2004
3.
Krebs  JWWheeling  JTChilds  JE Rabies surveillance in the United States during 2002. J Am Vet Med Assoc 2003;2231736- 1748
PubMedArticle
4.
Centers for Disease Control and Prevention, First human death associated with raccoon rabies—Virginia, 2003. MMWR Morb Mortal Wkly Rep 2003;521102- 1103
PubMed
5.
Centers for Disease Control and Prevention, Human death associated with bat rabies—California, 2003. MMWR Morb Mortal Wkly Rep 2004;5333- 35
PubMed
6.
 Human rabies prevention—United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP). [erratum in MMWR Morb Mortal Wkly Rep 1999;48:16 and MMWR Morb Mortal Wkly Rep 2000;49:737]. MMWR Recomm Rep 1999;481- 21
PubMed
7.
Helmick  CGTauxe  RVVernon  AA Is there a risk to contacts of patients with rabies? Rev Infect Dis 1987;9511- 518
PubMedArticle
8.
Noah  DLSmith  MGGotthardt  JC  et al.  Mass human exposure to rabies in New Hampshire: exposures, treatment, and cost. Am J Public Health 1996;861149- 1151
PubMedArticle
9.
Centers for Disease Control and Prevention, Investigation of rabies infections in organ donor and transplant recipients—Alabama, Arkansas, Oklahoma, and Texas, 2004. MMWR Morb Mortal Wkly Rep 2004;53586- 589
PubMed
10.
Centers for Disease Control and Prevention, Update: investigation of rabies infections in organ donor and transplant recipients—Alabama, Arkansas, Oklahoma, and Texas, 2004. MMWR Morb Mortal Wkly Rep 2004;53615- 616
PubMed
11.
Srinivasan  ABurton  ECKuehnert  MJ  et al.  Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005;3521103- 1111
PubMedArticle
12.
Rupprecht  CEHanlon  CAHemachudha  T Rabies re-examined. Lancet Infect Dis 2002;2327- 343
PubMedArticle
13.
Morimoto  KPatel  MCorisdeo  S  et al.  Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America. Proc Natl Acad Sci U S A 1996;935653- 5658
PubMedArticle
14.
Hemachudha  TPhuapradit  P Rabies. Curr Opin Neurol 1997;10260- 267
PubMedArticle
15.
Mrak  REYoung  L Rabies encephalitis in humans: pathology, pathogenesis and pathophysiology. J Neuropathol Exp Neurol 1994;531- 10
PubMedArticle
16.
Ray  NBEwalt  LCLodmel  DL Rabies virus replication in primary murine bone marrow macrophages and in human and murine macrophage-like cell lines: implications for viral persistence. J Virol 1995;69764- 772
PubMed
17.
Jackson  ACYe  HPhelan  CC  et al.  Extraneural organ involvement in human rabies. Lab Invest 1999;79945- 951
PubMed
18.
Warrell  MJWarrell  DA Rabies and other Lyssavirus diseases. Lancet 2004;363959- 969
PubMedArticle
19.
Warrell  DA The clinical picture of rabies in man. Trans R Soc Trop Med Hyg 1976;70188- 195
PubMedArticle
20.
Hemachudha  TLaothamatas  JRupprecht  CE Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet Neurol 2002;1101- 109
PubMedArticle
21.
Dupont  JREarle  KM Human rabies encephalitis: a study of forty-nine fatal cases with a review of the literature. Neurology 1965;151023- 1034
PubMedArticle
22.
Emmons  RWLeonard  LLDeGenaro  F  Jr  et al.  A case of human rabies with prolonged survival. Intervirology 1973;160- 72
PubMedArticle
23.
Neiman  JHaapaniemi  HMHillbom  M Neurological complications of drug abuse: pathophysiological mechanism. Eur J Neurol 2000;7595- 606
PubMedArticle
24.
Chehrenama  MZagardo  MTKoski  CL Subarachnoid hemorrhage in a patient with Lyme disease. Neurology 1997;48520- 523
PubMedArticle
25.
Jain  RDeveikis  JHickenbottom  SMukherji  SK Vericella-zoster vasculitis presenting with intracranial hemorrhage. AJNR Am J Neuroradiol 2003;24971- 974
PubMed
26.
Patey  OOllivaud  LBreuil  JLafaix  C Unusual neurologic manifestations occurring during dengue fever infection. Am J Trop Med Hyg 1993;48793- 802
PubMed
27.
Pleasure  SJFischbein  N Correlation of clinical and neuroimaging findings in a case of rabies encephalitis. Arch Neurol 2000;571765- 1769
PubMedArticle
28.
Mani  JReddy  BCBorgohain  R  et al.  Magnetic resonance imaging in rabies. Postgrad Med J 2003;79352- 354
PubMedArticle
29.
Desai  RVJain  VSingh  P  et al.  Radiculomyelitic rabies: can MR imaging help? AJNR Am J Neuroradiol 2002;23632- 634
PubMed
30.
Awasthi  MParmar  HPatankar  TCastillo  M Imaging findings in rabies encephalitis. AJNR Am J Neuroradiol 2001;22677- 680
PubMed
31.
Kleinschmidt-DeMasters  BKMarder  BALevi  ME  et al.  Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch Neurol 2004;611210- 1220
PubMedArticle
32.
Reddy  SASchucany  WGOpatowsky  MJ Altered mental status in a 66-year-old woman during the late summer months. Baylor University Medical Center Proceedings.2004;17:353-356
33.
Houff  SABurton  RCWilson  RW  et al.  Human-to-human transmission of rabies virus by corneal transplant. N Engl J Med 1979;300603- 604
PubMedArticle
34.
Gode  GRBhide  NK Two rabies deaths after corneal grafts from one donor. Lancet 1988;2791
PubMedArticle
35.
 Human-to-human transmission of rabies via corneal transplant—Thailand. MMWR Morb Mortal Wkly Rep 1981;30473- 474
PubMed
36.
 Imported human rabies—France, 1992. MMWR Morb Mortal Wkly Rep 1992;41953- 955
PubMed
37.
Centers for Disease Control and Prevention, Recovery of a patient from clinical rabies—Wisconsin, 2004. MMWR Morb Mortal Wkly Rep 2004;531171- 1173
PubMed
Original Contribution
June 2005

Rabies EncephalomyelitisClinical, Neuroradiological, and Pathological Findings in 4 Transplant Recipients

Author Affiliations

Author Affiliations: Departments of Pathology and Laboratory Medicine (Drs Burton, Watkins, and Chang), Radiology (Dr Opatowsky), Neurology (Dr El-Feky), Nephrology (Drs Fischbach and Melton), and Transplantation (Drs Klintmalm, Sanchez, and Randall), Baylor University Medical Center, Dallas, Tex; Department of Pathology and Laboratory Medicine (Dr Burns), University of Texas Southwestern Medical Center, Dallas.

Arch Neurol. 2005;62(6):873-882. doi:10.1001/archneur.62.6.873
Abstract

Background  Three patients received solid organ transplants from a common donor and were subsequently discharged from the hospital following an uneventful hospital course. Within 30 days, all 3 organ recipients returned to the hospital with varying symptoms that progressed to rapid neurological deterioration, coma, and death.

Objective  To describe the clinical, neuroradiological, and pathological findings of rabies virus infection in organ transplant recipients infected from a common donor.

Design  Case series involving a common donor and 3 organ recipients ascertained through review of clinical course and autopsy findings. A fourth case was determined by review of pending autopsy cases in which death occurred within the same time interval. Portions of postmortem central nervous system and organ tissues were frozen and formalin-fixed. Fluids and tissues were also collected for cultures, serology, and molecular studies. Postmortem fluids and tissues and antemortem fluids and tissues from all 4 transplant recipients and serum and banked lymphocyte or spleen cells from the donors were sent to the Centers for Disease Control and Prevention for further evaluation.

Setting  Transplant unit of an urban teaching hospital.

Results  Antemortem cerebrospinal fluid analysis for 3 of the 4 recipients was consistent with a viral etiology. Neuroimaging and electroencephalogram studies were suggestive of an infectious encephalitis or a toxic encephalopathy. Initial laboratory testing did not demonstrate an infectious etiology. Postmortem histologic analysis, immunohistochemistry, electron microscopy, and direct fluorescence antibody testing revealed rabies virus infection. Serological testing done postmortem confirmed rabies virus infection in the common donor.

Conclusions  These cases demonstrate a risk for transmitting rabies virus infection through solid organ and tissue transplantation, and this diagnosis should be considered in any rapidly progressing neurological disease.

Rabies is one of the most feared diseases in human history, with reports of recognizable cases dating back to the 23rd century BC. Rabies is a zoonosis that can affect both wild and domesticated animals. Although many mammals may become infected, the prevalence of infection varies considerably from continent to continent. Increasingly, bats have been recognized as an important reservoir. Transmission in humans occurs primarily through the bite of an infected animal; in the United States, it most commonly comes from bats.15 Human-to-human transmission of rabies has been described.6 There have been 8 documented cases of rabies transmission through corneal transplants, of which 1 occurred in the United States.6,7 There have been no previously reported cases of rabies transmission through solid organ transplantation. Although human rabies cases in the United States are rare, the incidence is probably underestimated owing to the absence of a known animal exposure, lack of clinical suspicion, difficulty in making an antemortem diagnosis, and decreasing autopsy numbers.8 This report describes 4 cases in which transmission of the rabies virus occurred through solid organ transplantation and a vascular allograft. Postmortem examination permitted the diagnosis of transplant-associated rabies infection. Summaries of these cases have been previously reported by the Centers for Disease Control and Prevention (Atlanta, Ga).911

METHODS

The donor case and first 3 organ recipient cases were discovered through contact with physicians of the transplant team, medical record review, and review of laboratory and imaging data and autopsy findings. A fourth case was determined by a review of pending transplant recipient autopsies that occurred within the same time interval. The transplant recipients developed an encephalopathy that progressed to coma and death and underwent a full postmortem examination. The donor did not undergo postmortem examination. Postmortem central nervous system (CNS) and organ tissues were frozen (−70°) and formalin-fixed for 1 to 7 days. Tissue for histologic analysis was routinely processed, sectioned, and stained with hematoxylin-eosin. Various postmortem fluids and cerebrospinal fluid (CSF) and antemortem blood and CSF were held for further analysis. Postmortem cultures, serology, and molecular studies were conducted on site. Postmortem formalin-fixed tissues and paraffin-embedded tissues from all 4 patients, frozen CNS and organ tissue from 3 of the 4 patients, postmortem fluids and antemortem fluids from all 4 recipients, and serum and banked lymphocyte or spleen cells from the donors were sent to the Centers for Disease Control and Prevention for further evaluation.

RESULTS

Two males and 2 females, aged 18 to 55 years, received organs or vascular tissue from a common donor who developed rapid neurological deterioration and died with clinically unsuspected rabies infection. The lungs, kidneys, liver, and vascular allograft were harvested for transplantation after donor screening. The lungs were transplanted into a man who died at the time of operation of surgical complications. The 2 kidneys, the liver, and a vascular allograft were successfully transplanted into 4 recipients. All 4 transplant recipients developed rapidly progressive neurological disease and died within 48 days following transplantation.

PRODROME AND CLINICAL FEATURES OF DONOR AND TRANSPLANT RECIPIENTS

Table 1summarizes the demographic characteristics, immunosuppressant therapy, symptoms, and selected clinical laboratory findings for the donor and the 4 transplant recipients.

DONOR

The donor had twice visited an emergency department in the preceding 24 hours with complaints of nausea, vomiting, and abdominal pain. He then visited a different emergency department with worsening abdominal pain, nausea, hematemesis, throat pain, and intermittent periods of confusion and agitation and was noted to have ballistic movement of his trunk. When he first arrived, his vital signs were stable; however, within 6 hours he developed tachycardia and hypertension. Because of his agitation and inability to cooperate, he was sedated and intubated before technicians performed a computed tomography (CT) scan of the head that revealed a small subarachnoid hemorrhage (SAH). Over the next 8 hours, he became increasingly agitated (pulling at his restraints, biting the endotracheal tube, and attempting to self-extubate). He was admitted to the intensive care unit for acute cocaine-induced SAH, hypertensive crisis, and rhabdomyolysis (creatinine kinase, 8061 U/L). During the physical examination, his temperature was mildly elevated at 100.5° (oral), his pupils were equal and reactive, his neck was supple, his heart examination result was significant for tachycardia with a regular to irregular rhythm, and his breath sounds were significant for faint crackles and rales that cleared with suctioning. A repeat creatinine kinase level was 3404 U/L; creatinine kinase-MB fraction, 7.9%; and MB index, 0.2. A second troponin I level was 0.44 ng/mL (the initial troponin I level was within normal limits). He was weaned from the ventilator and extubated and continued to have episodes of coughing, retching, and vomiting. He developed generalized tonic-clonic seizures and was reintubated. He remained hypertensive (blood pressure, 199/110 mm Hg) and tachycardic (pulse, 187), and he was diaphoretic and febrile (101.8°). A third troponin I level was 3.61 ng/mL. He continued to have seizure activity, biting his endotracheal tube and tongue, and self-extubated. He soon became apneic and hypotensive and was reintubated. His seizure activity continued and his temperature increased to 106.5°. A neurology consult was obtained at which time he was noted to have absent motor and sensory responses, fixed dilated pupils, and decreased tone and flexor plantar responses. A repeat CT scan was now significant for a large SAH and evidence of herniation. Oculocephalic, gag, and cough reflexes were now absent. An electroencephalogram showed only muscle activity from agonal breaths. A perfusion study was negative for cerebral blood flow, and he was declared brain dead 92 hours after he arrived at the emergency department. Permission was granted for organ donation, and his lungs, kidneys, liver, and iliac vessels were harvested the following day.

TRANSPLANT RECIPIENTS

The 3 solid organ recipients were transplanted on the same day, and the vessel allograft was used for hepatic artery reconstruction in another liver-transplant recipient the following day. The 3 solid organ recipients were all discharged home following transplantation. By the 27th day following transplantation, the 3 organ recipients had been readmitted to the hospital with complex symptoms (Table 2) that rapidly progressed to coma and death. Patient 1 was the first to arrive (day 21) with symptoms of sleep deprivation, tremors, decreased appetite, and abdominal and back pain. Patient 2 was previously admitted 19 days posttransplantation with hydronephrosis and mild acute cellular rejection and was discharged with a nephrostomy tube in place. She was readmitted on posttransplantation day 27 with myalgia, worsening abdominal pain, right flank pain, and itching. She underwent an appendectomy for suspected appendicitis. Patient 3 was admitted to an outside hospital on posttransplantation day 27 with acute delirium, myoclonus, myalgia, and diaphoresis. A urine toxicology screen at the outside hospital was positive for methamphetamines. He was transferred to our hospital the same day and later underwent a transplant nephrectomy for a failed graft. The artery allograft recipient’s hospital course was complicated by wound dehiscence, abdominal abscesses, and hepatic artery stenosis, necessitating 2 additional returns to the operating room. On posttransplant day 26, she developed mental status changes and suicidal ideations.

All 4 recipients had rapid neurological deterioration with episodic periods of agitation, restlessness, delirium, and hallucinations. Three of the 4 patients had tremors or myoclonus (patients 1, 3, and 4) and 2 had seizures (patients 2 and 4). All 4 recipients developed respiratory failure requiring intubation, fever, excessive oral secretions, cardiac rhythm disturbances (2 patients required temporary pacemaker placement), hypotension, paralysis, coma, and progressive absence of brainstem reflexes and died within 7 to 23 days (median, 11.5 days) of the onset of neurological symptoms.

ANTEMORTEM DIAGNOSTIC STUDIES
Laboratory Evaluation

Cerebrospinal fluid analysis was performed for patients 1, 3, and 4. All had increased nucleated cells (mean, 13; range, 7-32), 2 had increased protein (69 mg/dL and 227 mg/dL), and all had normal glucose levels (mean, 3.49 mmol/L [63 mg/dL]; range, 3.28-3.49 mmol/L [59-63 mg/dL]). Repeat CSF analysis was done on 2 of the recipients (patients 3 and 4), and the number of nucleated cells and protein levels increased. Viral culture results (CSF) were negative in all 3 recipients (Table 1). Arbovirus test results (West Nile, St Louis encephalitis, and dengue viruses) were negative in patients 1, 2, and 3. A West Nile virus IgG antibody test result was positive, and an IgM antibody test result was indeterminate in patient 4, results confirmed by the Texas Department of Health. Test results for cytomegalovirus infection by reverse-transcriptase polymerase chain reaction for all 4 recipients; herpes simplex virus test results for patients 1, 3, and 4; and the human herpesvirus-6 test result for patient 4 were negative. Immunosuppressant therapy was increased in patients 2 and 4 (Table 1), requiring dosage adjustments.

Neuroimaging and Electroencephalogram Evaluation

Cranial magnetic resonance imaging (MRI) and CT examinations were performed on all 4 transplant recipients. Routine protocol MRI brain studies were performed to include fluid-attenuated inversion recovery and diffusion weighted acquisitions.

The MRI result was significant for increased fluid-attenuated inversion recovery signal in the periventricular white matter (patient 2), leptomeninges (patients 1 and 3), medial temporal lobes (patients 1 and 3), inferior frontal lobes (patient 1), subinsular cortex (patient 4), precentral gyrus (patient 4), basal ganglia (patients 1, 3, and 4), thalami (patients 1 and 3), midbrain (patients 1 and 3), hippocampi (patient 3), cerebral peduncles (patient 1), and cerebellum (patient 1) (Figure 1 and Figure 2).

Initial CT scans in all 4 patients showed no intracranial abnormalities.

Repeat CT scans in 2 patients revealed marked interval changes. On posttransplant day 36, patient 2 had evidence of profound cerebral edema with herniation. On posttransplant day 40, patient 3 had CT findings of ischemic changes in the left fronto-occipital areas and vague signal attenuation in the superior posterior putamen.

Electroencephalogram studies (Table 3) in all patients showed moderate to severe generalized slowing in the theta to delta range. Patient 4’s EEG showed electroencephalographic seizures that were refractory to treatment. In both patient 2 and patient 4, moderate to large amplitude slowing progressed to attenuated delta slowing as their encephalopathy progressed. Prominent occipital slowing was seen in patient 2; it was thought to reflect cyclosporine-induced posterior reversible encephalopathy. A repeat EEG showed electrocerebral silence 5 days later when she developed signs of cerebral herniation.

Postmortem Evaluation

Available onsite testing of multiple postmortem samples was exhausted without demonstrating an infectious etiology to explain the neurological symptoms. Macroscopic examination of the CNS varied among all of the transplant recipients. Patient 1 had congestion; irregularly distributed discoloration of the cortical mantle; generalized softening and edema of the striatum, thalamic nuclei, midbrain, and pons; herniation of the left hippocampal gyrus and right cerebellar tonsil; and Duret hemorrhages involving the midbrain and pontine tegmentum. Patient 2 had congestion, generalized edema, and evidence of tonsillar herniation. Patient 3 had brainstem flattening; softening of the left insular cortex and inferolateral putamen most pronounced at the level of the rostral hippocampus; and petechial hemorrhages involving the insular cortex, the ependymal lining of the lateral ventricles, and the upper thoracic spinal cord. Patient 4 had mild generalized edema and congestion.

Histologic hematoxylin-eosin–stained sections in all 4 patients demonstrated widespread neuronal necrosis involving the cerebral cortex, hippocampus, and dentate nucleus of the cerebellum, accompanied by substantial Purkinje cell loss and Bergmann gliosis, which is consistent with global hypoxic-ischemic injury. In addition to these changes, patient 1 had Duret hemorrhages in the brainstem. The brain of patient 3 showed innumerable punctuate hemorrhages and multiple acute and organizing infarcts involving the left frontoparietal and insular cortex, basal ganglia, hippocampi, and cervical spinal cord. An acute encephalomyelitis characterized by a brisk lymphohistiocytic infiltrate, perivascular lymphocytic infiltration, glial nodules, and neuronophagia was present in the cortical gray matter, deep gray structures, and inferior olivary nuclei; it was accompanied by patchy, less severe inflammatory changes in the white matter in all 4 recipients (Figure 3A and C). Although the extensive hypoxic ischemic changes obscured much of the neuronal morphology, eosinophilic intracytoplasmic viral inclusion bodies of varying sizes consistent with Negri bodies were present in multiple neurons, most prominently within residual Purkinje cells, and larger neurons of the brainstem (Figure 3B and D). A patchy lymphocytic leptomeningeal inflammatory infiltrate was present in all 4 recipients. Ganglionitis was present in the thoracic dorsal root ganglia of patients 2 and 3 with occasional Negri inclusions seen in the ganglion cells. Mononuclear inflammatory infiltrates were also present in the neurohypophysis in patient 3, in the nerves of the transplanted kidneys in patients 2 and 3, in the liver in patient 1, surrounding the iliac artery conduit in patient 4, and within epicardial nerves in patient 3. In addition to the epicardial infiltrates, patient 3 also had a significant myocarditis characterized by multifocal dense mononuclear inflammatory infiltrates involving the myocardium with associated myocardial necrosis. There were mild chronic inflammatory infiltrates seen in postmortem sural nerve segments from patients 2 and 3.

Rabies virus infection was confirmed by multiple methods (Centers for Disease Control and Prevention), including immunohistochemistry, direct antibody fluorescence, cell cultures, mouse inoculations, and electron microscopy. Serological testing was positive for IgG antibodies to rabies in patient 4, positive for IgG and IgM antibodies in patients 1 and 3 and the common donor, and negative for IgG and IgM antibodies in patient 3. Preliminary antigenic characterization of the rabies virus was consistent with a rabies virus variant associated with insectivorous bats.

COMMENT

Rabies has been described as an unpredictable disease with the only consistent feature being its uncharacteristic symptoms.12 We have described a unique and uncharacteristic transmission of rabies virus infection through the transplantation of multiple organs and an arterial allograft. Rabies virus is transmitted through a bite (via saliva) in the classic form or can be transmitted through a scratch, in bat-variant rabies. The virus then incubates at the inoculation site for a period ranging from 5 days up to several years (average, 30-60 days), depending on the size of the inoculum and the severity and location of the wound. During the incubation period, the virus then replicates locally in muscle cells (classic form) or in the epidermis and dermis (bat-variant rabies), whereby replication has been shown to occur at lower temperatures and with higher infectivity in nonneuronal cells, including fibroblasts, macrophages, and epithelial cells.1316 The virus then attaches to nerve endings and moves centripetally from the periphery to dorsal root ganglia and then on to the CNS by fast axonal transport. In the CNS, the virus has a predilection for the brainstem, thalamus, basal ganglia, and spinal cord, where it selectively replicates intraneuronally, producing an encephalomyelitis, and eventually spreads centrifugally along neural pathways to multiple organ and tissue sites.17,18 Approximately 80% of patients develop an encephalitic (furious) form, and the remaining patients develop a paralytic (dumb) form of the disease.19

In classic rabies, a multitude of nonspecific symptoms can occur during the prodromal phase; they generally last only a few days, up to 1 week, and signify movement of the virus from the periphery to the CNS. Central nervous system infection results in an acute neurological phase, in which initial symptoms commonly include fever and hyperactivity. Patients may have intermittent periods of hyperactivity, disorientation, confusion, bizarre behavior, agitation, aggression, or hallucinations, either occurring spontaneously or precipitated by sensory stimuli. During this stage, patients may also develop autonomic dysfunction (eg, excessive salivation, piloerection, lacrimation, sweating), cranial nerve signs, muscle fasciculations, tremor, myoclonus, nuchal rigidity, or paralysis.20 Classic hydrophobia is only seen in approximately 30% to 50% of patients, although most patients have some difficulty in swallowing or throat pain.15 Although biting behavior in humans is unusual, it has been reported to occur.21,22

The cardinal signs of classic rabies (encephalitic form) include fluctuating consciousness, phobic spasms, and autonomic dysfunction.20 Patients with bat rabies virus infection can have clinical features different from those of classic rabies. Patients infected with the bat-variant rabies more commonly have local symptoms or neuropathic pain at the inoculation site described as burning, numbness, tingling, or itching. A history of an antecedent bite may be lacking. Anisocoria, bilateral ptosis, diplopia, nystagmus, pinpoint pupils, intermittent facial nerve palsy, and tremor have also been reported. During the acute neurological stage, nerve conduction abnormalities and weakness in the bitten limb, myoclonus, hemiparesis, hemisensory loss, asymmetry of deep tendon reflexes, and cranial nerve and brainstem involvement have been reported to occur. Seizures are generally rare but are also more often seen in patients infected with bat rabies.14

The acute neurological phase generally lasts between 2 and 7 days and then, as the virus disseminates more widely throughout the CNS, progresses to paralysis and coma. Death generally occurs from failure of basic central vegetative functions or can be due to myocarditis. Hematemesis is seen in 30% to 60% of the patients 6 to 12 hours before death.14

It is during the acute neurological phase that most patients come to the hospital. The differential diagnosis is quite broad during this phase, and making a diagnosis is particularly difficult in the absence of a history of an animal bite or exposure. This was the case for the donor and the 3 organ recipients. Prior to donation, the donor’s family denied a history of animal exposure when asked by the organ bank whether the donor had experienced animal bites. However, after a diagnosis of rabies was made, further investigation revealed that the donor had been bitten by a bat, as recalled by his friends. The case of the fourth patient was even more perplexing in that she had never left the hospital because of postoperative complications, including abdominal abscesses, sepsis, and hepatic artery stenosis. Although the possibility of a primary CNS infection was considered in the differential for the transplant recipients, it was not considered for the donor. The donor’s habits, symptoms, clinical course, laboratory data, and imaging findings all were reasonably attributed to acute cocaine toxicity at the time of his death.23 Similarly, in the case of 1 of the kidney recipients (patient 3), a recent history of drug use resulted in suspicion of methamphetamine toxicity.

Imaging studies of the brain in the donor and 4 recipients varied. The donor had CT evidence of an SAH, and although this has not previously been described in rabies virus infection, there are reports of SAH associated with other types of vector-borne24 and viral25,26 encephalitides. In patient 1, marked MRI signal abnormalities were seen by day 28, and profound CT and MRI abnormalities were apparent in patients 2, 3, and 4 between posttransplant days 34 and 36. Not unlike other reported cases, these patients showed preferential involvement of the basal ganglia, thalami, and brainstem.2730 The sizable left middle cerebral artery infarct in patient 3 and restricted diffusion surrounding the motor strip in patient 4 are atypical features for rabies virus infection. Interpretation of the imaging findings was challenging in that the abnormalities seen were nonspecific and prospectively raised concerns for other, more common encephalitic diseases, including any number of toxic/metabolic insults, herpes simplex virus infection, and West Nile virus infection. Similar imaging abnormalities have been described in transplant recipients with proven West Nile virus encephalitis.31,32

The differential was further clouded by other infectious and noninfectious complications known to occur in the early transplantation period. Most of the common infections seen in the early transplantation period were considered in all 4 of the recipients and essentially ruled out in all but 1 (patient 4), resulting in further consideration of a toxic/metabolic encephalopathic process. Patient 2 had elevated cyclosporine levels, and patient 4 had a mildly elevated tacrolimus level, requiring dosage adjustments.

Although antemortem diagnosis of rabies is possible by demonstrating rabies virus ribonucleic acid, antigen, and antibodies in skin and brain biopsies, CSF, saliva, and blood, the possibility of rabies is often not considered, particularly in the absence of a known exposure. In the cases discussed here, a definitive diagnosis of rabies was not made until after death, similar to previous reports in which more than one third of cases were not diagnosed antemortem primarily because of lack of clinical suspicion.1 Human-to-human transmission of rabies, although rare, has been described to occur through corneal transplants.6,3336 Although the risk for rabies transmission through solid organ transplantation has always existed,20 transmission through solid organ transplantation has not been previously described. This series of cases along with a subsequent case37 brings the number of reported human rabies cases since 1980 in the United States to 55.14,27 Even if the number of US rabies cases increased by 100-fold, given the population and known organ donation rate, a conservative estimated risk of rabies infection through solid organ transplantation is less than 1:1 000 000 000 000. However, these cases demonstrate that the risk for transmission of rabies infection through solid organ and tissue transplantation exists, and the diagnosis should be considered in any rapidly progressing neurological disease. Moreover, although rabies infection is almost always fatal once symptoms occur, prompt antemortem or postmortem diagnosis remains necessary to implement appropriate infection-control measures and prophylaxis to decrease the risk of disease.

Back to top
Article Information

Correspondence: Elizabeth C. Burton, MD, Department of Pathology and Laboratory Medicine, Baylor University Medical Center, 5th Fl Y-Wing, 3500 Gaston Ave, Dallas, TX 75246 (LizBu@BaylorHealth.edu).

Accepted for Publication: March 30, 2005.

Author Contributions:Study concept and design: Burton and Klintmalm. Acquisition of data: Burton, Opatowsky, El-Feky, Fischbach, Melton, Watkins, Chang, and Klintmalm. Analysis and interpretation of data: Burton, Burns, Opatowsky, El-Feky, Sanchez, Randall, Watkins, and Klintmalm. Drafting of the manuscript: Burton, Burns, Opatowsky, and El-Feky. Critical revision of the manuscript for important intellectual content: Burton, Burns, Opatowsky, El-Feky, Fischbach, Melton, Sanchez, Randall, Watkins, Chang, and Klintmalm. Administrative, technical, and material support: Burton, Opatowsky, Melton, Sanchez, Randall, and Klintmalm. Study supervision: Burton, Melton, and Klintmalm.

References
1.
Noah  DLDrenzek  CLSmith  JS  et al.  Epidemiology of human rabies in the United States, 1980 to 1996. Ann Intern Med 1998;128922- 930
PubMedArticle
2.
Centers for Disease Control and Prevention Cases of rabies in human beings in the United States, by circumstances of exposure and rabies virus variant, 1990-2001.  Available at:http://www.cdc.gov/ncidod/dvrd/rabies/professional/publications/surveillance/surveillance01/table2-01.htm. Accessed September 7, 2004
3.
Krebs  JWWheeling  JTChilds  JE Rabies surveillance in the United States during 2002. J Am Vet Med Assoc 2003;2231736- 1748
PubMedArticle
4.
Centers for Disease Control and Prevention, First human death associated with raccoon rabies—Virginia, 2003. MMWR Morb Mortal Wkly Rep 2003;521102- 1103
PubMed
5.
Centers for Disease Control and Prevention, Human death associated with bat rabies—California, 2003. MMWR Morb Mortal Wkly Rep 2004;5333- 35
PubMed
6.
 Human rabies prevention—United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP). [erratum in MMWR Morb Mortal Wkly Rep 1999;48:16 and MMWR Morb Mortal Wkly Rep 2000;49:737]. MMWR Recomm Rep 1999;481- 21
PubMed
7.
Helmick  CGTauxe  RVVernon  AA Is there a risk to contacts of patients with rabies? Rev Infect Dis 1987;9511- 518
PubMedArticle
8.
Noah  DLSmith  MGGotthardt  JC  et al.  Mass human exposure to rabies in New Hampshire: exposures, treatment, and cost. Am J Public Health 1996;861149- 1151
PubMedArticle
9.
Centers for Disease Control and Prevention, Investigation of rabies infections in organ donor and transplant recipients—Alabama, Arkansas, Oklahoma, and Texas, 2004. MMWR Morb Mortal Wkly Rep 2004;53586- 589
PubMed
10.
Centers for Disease Control and Prevention, Update: investigation of rabies infections in organ donor and transplant recipients—Alabama, Arkansas, Oklahoma, and Texas, 2004. MMWR Morb Mortal Wkly Rep 2004;53615- 616
PubMed
11.
Srinivasan  ABurton  ECKuehnert  MJ  et al.  Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005;3521103- 1111
PubMedArticle
12.
Rupprecht  CEHanlon  CAHemachudha  T Rabies re-examined. Lancet Infect Dis 2002;2327- 343
PubMedArticle
13.
Morimoto  KPatel  MCorisdeo  S  et al.  Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America. Proc Natl Acad Sci U S A 1996;935653- 5658
PubMedArticle
14.
Hemachudha  TPhuapradit  P Rabies. Curr Opin Neurol 1997;10260- 267
PubMedArticle
15.
Mrak  REYoung  L Rabies encephalitis in humans: pathology, pathogenesis and pathophysiology. J Neuropathol Exp Neurol 1994;531- 10
PubMedArticle
16.
Ray  NBEwalt  LCLodmel  DL Rabies virus replication in primary murine bone marrow macrophages and in human and murine macrophage-like cell lines: implications for viral persistence. J Virol 1995;69764- 772
PubMed
17.
Jackson  ACYe  HPhelan  CC  et al.  Extraneural organ involvement in human rabies. Lab Invest 1999;79945- 951
PubMed
18.
Warrell  MJWarrell  DA Rabies and other Lyssavirus diseases. Lancet 2004;363959- 969
PubMedArticle
19.
Warrell  DA The clinical picture of rabies in man. Trans R Soc Trop Med Hyg 1976;70188- 195
PubMedArticle
20.
Hemachudha  TLaothamatas  JRupprecht  CE Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet Neurol 2002;1101- 109
PubMedArticle
21.
Dupont  JREarle  KM Human rabies encephalitis: a study of forty-nine fatal cases with a review of the literature. Neurology 1965;151023- 1034
PubMedArticle
22.
Emmons  RWLeonard  LLDeGenaro  F  Jr  et al.  A case of human rabies with prolonged survival. Intervirology 1973;160- 72
PubMedArticle
23.
Neiman  JHaapaniemi  HMHillbom  M Neurological complications of drug abuse: pathophysiological mechanism. Eur J Neurol 2000;7595- 606
PubMedArticle
24.
Chehrenama  MZagardo  MTKoski  CL Subarachnoid hemorrhage in a patient with Lyme disease. Neurology 1997;48520- 523
PubMedArticle
25.
Jain  RDeveikis  JHickenbottom  SMukherji  SK Vericella-zoster vasculitis presenting with intracranial hemorrhage. AJNR Am J Neuroradiol 2003;24971- 974
PubMed
26.
Patey  OOllivaud  LBreuil  JLafaix  C Unusual neurologic manifestations occurring during dengue fever infection. Am J Trop Med Hyg 1993;48793- 802
PubMed
27.
Pleasure  SJFischbein  N Correlation of clinical and neuroimaging findings in a case of rabies encephalitis. Arch Neurol 2000;571765- 1769
PubMedArticle
28.
Mani  JReddy  BCBorgohain  R  et al.  Magnetic resonance imaging in rabies. Postgrad Med J 2003;79352- 354
PubMedArticle
29.
Desai  RVJain  VSingh  P  et al.  Radiculomyelitic rabies: can MR imaging help? AJNR Am J Neuroradiol 2002;23632- 634
PubMed
30.
Awasthi  MParmar  HPatankar  TCastillo  M Imaging findings in rabies encephalitis. AJNR Am J Neuroradiol 2001;22677- 680
PubMed
31.
Kleinschmidt-DeMasters  BKMarder  BALevi  ME  et al.  Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch Neurol 2004;611210- 1220
PubMedArticle
32.
Reddy  SASchucany  WGOpatowsky  MJ Altered mental status in a 66-year-old woman during the late summer months. Baylor University Medical Center Proceedings.2004;17:353-356
33.
Houff  SABurton  RCWilson  RW  et al.  Human-to-human transmission of rabies virus by corneal transplant. N Engl J Med 1979;300603- 604
PubMedArticle
34.
Gode  GRBhide  NK Two rabies deaths after corneal grafts from one donor. Lancet 1988;2791
PubMedArticle
35.
 Human-to-human transmission of rabies via corneal transplant—Thailand. MMWR Morb Mortal Wkly Rep 1981;30473- 474
PubMed
36.
 Imported human rabies—France, 1992. MMWR Morb Mortal Wkly Rep 1992;41953- 955
PubMed
37.
Centers for Disease Control and Prevention, Recovery of a patient from clinical rabies—Wisconsin, 2004. MMWR Morb Mortal Wkly Rep 2004;531171- 1173
PubMed
×